Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoprolol versus carvedilol in maintenance hemodialysis patients: effects on heart rate variability
TCTR20260921004Not yet recruiting
- Sponsor
- Faculty of Medicine, Chiang Mai University
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in hypertension (HTN) and end-stage kidney disease (ESKD) comparing Metoprolol with Carvedilol (2 arms). Primary endpoints: Change in heart rate variability at 6 months in carvedilol group and Change in heart rate variability at 6 months in metoprolol group. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
metoprololcarvedilol
03
Conditions
hypertension (HTN)end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on TCTR20260921004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260921004.